Drugs / Ayahuasca

Trials 6

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT02914769 Feb 2014 → Dec 2016 major depressive disorder Federal University of Rio Grande do Norte Completed No outcome recorded
Phase 23 trials
Phase 2 NCT07317206 Dec 2025 → Jun 2026 overdue post-traumatic stress disorder University of Sao Paulo Recruiting No outcome recorded
Phase 2 NCT07212946 Oct 2022 → Oct 2024 major depressive disorder University of Sao Paulo Completed No outcome recorded
Phase 2 NCT06150859 Oct 2021 → Apr 2024 — Beckley Med Foundation Unknown No outcome recorded
Phase not applicable2 trials
— NCT07317232 Dec 2025 → Jun 2026 overdue — University of Sao Paulo Recruiting No outcome recorded
— NCT07317219 Dec 2025 → Jun 2026 overdue — University of Sao Paulo Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Ayahuasca “This paper introduces a protocol for a clinical trial exploring the effectiveness of a Meaning Reconstruction psychotherapy approach (MR) assisted with ayahuasca, a traditional...” PMID 39839135 ↗ Jan 2025
5

NCT07317219 ↗

NCT07212946 ↗

NCT07317232 ↗

NCT07317206 ↗

NCT02914769 ↗

Modality Traditional medicine (herbal / TCM) “Ayahuasca is a decoction of two plants, long used by Amazonian Amerindians.” NCT02914769 ↗
Route Oral “Effects begin at 30-40 min after oral intake” NCT02914769 ↗